Loading asset research
DiaMedica Therapeutics Inc. Common Stock
DMACNasdaq · USD · StocksQuote as of · Exchange session not verified$6.47
0.00%
Today
DMAC
Loading 1D prices…
Market cap
$348.9M
Volume
123.6K
52w high
$10.4252w low
$5.24Company profile
DiaMedica Therapeutics Inc. Common Stock
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Minneapolis, MN, United States
Employees
35
Fiscal year end
1231
CIK
1401040
Session & valuation
Open$6.57
Previous close$6.47
Day high$6.88
Day low$6.33
30-day avg. volume133.9K
Outstanding shares53.9M
Diluted EPS-$0.70
Latest annual period
P/E (trailing)-9.24
P/E (forward)-8.01
Price / book9.10
Beta0.97
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SIONSionna Therapeutics Inc. Common Stock | $354.4M | $0.00 | — | -$1.88 | +2.76% | Hold |
| PRLDPrelude Therapeutics Incorporated Common Stock | $366.3M | $12.1M | -819.60% | -$1.29 | -1.50% | Buy |
| ZNTLZentalis Pharmaceuticals Inc. Common Stock | $332.3M | $0.00 | — | -$1.91 | -2.51% | Buy |
| RCKTRocket Pharmaceuticals Inc. Common Stock | $367.7M | $0.00 | — | -$2.01 | -3.88% | Hold |
| QTTBQ32 Bio Inc. Common Stock | $330.4M | $53.7M | +55.46% | $2.42 | +3.54% | Buy |